Results 151 to 152 of about 4,214,171 (152)

Is radiolabelling a PARP inhibitor with a radiometal via a DOTA chelator a viable strategy for PARP-targeted radionuclide therapy (TRT)?

EANM Innovation
Kurniawan, Ahmad, Ming, Zihe, Boëtius, Melody, Szymanski, Wiktor, Blok, S., Elsinga, Philip H., F. Antunes, Ines, de Vries, E., Cornelissen, Bart   +8 more
openaire   +1 more source

The Evolving Landscape of Tissue-Agnostic Therapies in Precision Oncology

Ca-A Cancer Journal for Clinicians
Bettina Ryll, Vivek Subbiah, Razelle Kurzrock   +2 more
exaly